HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yves P Auberson Selected Research

Yves P Auberson Research Topics

Disease

2Multiple Sclerosis
06/2015 - 04/2011
2Narcolepsy
02/2015 - 08/2014
1Sleep Wake Disorders
01/2019
1Sleep Initiation and Maintenance Disorders (Insomnia)
01/2019
1Treatment-Resistant Depressive Disorder
10/2014
1Schizophrenia (Dementia Praecox)
10/2014
1Dyskinesias (Dyskinesia)
05/2013
1Major Depressive Disorder (Major Depressive Disorders)
07/2011
1Parkinsonian Disorders (Parkinsonism)
07/2008
1Status Epilepticus (Complex Partial Status Epilepticus)
10/2007
1Amnesia (Dissociative Amnesia)
03/2006
1Pain (Aches)
11/2005
1Inflammation (Inflammations)
11/2005

Drug/Important Bio-Agent (IBA)

4N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
10/2014 - 11/2005
3Histamine H3 Receptors (Histamine H3 Receptor)IBA
01/2019 - 08/2014
2sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
06/2015 - 04/2011
2Fingolimod Hydrochloride (FTY720)FDA Link
06/2015 - 04/2011
2Sphingosine-1-Phosphate ReceptorsIBA
06/2015 - 04/2011
2ErgolinesIBA
02/2015 - 08/2014
2N-Methylaspartate (NMDA)IBA
10/2014 - 11/2005
1siponimodIBA
06/2015
1IndolesIBA
02/2015
1Levodopa (L Dopa)FDA LinkGeneric
05/2013
15- (alpha- methyl- 4- bromobenzylamino)phosphonomethyl- 1,4- dihydroquinoxaline- 2,3- dioneIBA
05/2013
1Ro 25-6981IBA
05/2013
1Metabotropic Glutamate 5 ReceptorIBA
07/2011
1Oxidopamine (6 Hydroxydopamine)IBA
07/2008
1Chelating AgentsIBA
10/2007
1Glutamic Acid (Glutamate)FDA Link
10/2007
1Kainic Acid Receptors (Kainate Receptor)IBA
03/2006

Therapy/Procedure

1Oral Administration
04/2011